Dongfang Liu

Title: The Innovative Contributions of Dongfang Liu

Introduction

Dongfang Liu is a prominent inventor based in Millburn, NJ (US). He has made significant contributions to the field of immunotherapy, particularly in the development of methods and compositions for generating enhanced immunotherapeutic cells. With a total of 3 patents to his name, Liu's work is paving the way for advancements in cancer treatment and infectious disease management.

Latest Patents

Liu's latest patents include groundbreaking innovations. One of his notable patents is focused on the "Expansion of natural killer and chimeric antigen receptor-modified cells." This patent discloses methods and compositions for generating immunotherapeutic cells, such as NK and T cells, with enhanced cytotoxicity and capacity for expansion. The methods can further be utilized for the enhanced expansion of CAR-modified NK and T cells, which exhibit increased cytotoxicity. Another significant patent is titled "S309 chimeric antigen receptors and methods of use." This patent provides chimeric antigen receptors (CARs) that include an scFv binding to the coronavirus spike protein, along with nucleic acids encoding the CARs, vectors, and cells expressing the CARs. The methods described also include treating subjects with coronavirus by administering modified immune cells expressing the disclosed CAR.

Career Highlights

Throughout his career, Dongfang Liu has worked with esteemed institutions such as Rutgers, the State University of New Jersey, and Houston Methodist Hospital. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in immunotherapy.

Collaborations

Liu has collaborated with talented individuals, including Minh Ma and Saiaditya Badeti. These collaborations have further enriched his research and development efforts, leading to innovative solutions in the medical field.

Conclusion

Dongfang Liu's contributions to immunotherapy through his patents and collaborations highlight his role as a key innovator in the field. His work continues to inspire advancements that may significantly impact the treatment of various diseases.